glp 1 gastroparesis Diabetic and Glycaemic Control | Current Diabetes Reports Unmasking Semaglutide-Induced Gastroparesis: The Dangers

There are also side effects to taking GLP-1s, most of which are related to gastrointestinal issues

(2019) showed that diabetes could damage the integrity of the Neurovascular unit (NVU) in the hippocampus and reduce BDNF levels in endothelial cells and HT22 hippocampal neurons

doi: 10.33549/physiolres.933822 24 HusainM.BirkenfeldA

However, these adjusted thresholds have not been formally incorporated into FDA labeling for GLP-1 medications, creating a significant gap where Asian patients may have clear metabolic indications for treatment but fail to meet the standard BMI criteria

The trial demonstrated a significant reduction of 25% in the primary composite outcome of cardiovascular death and first HFH (19.4% versus 24.7% [HR 0.75